Literature DB >> 7790461

Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting.

N S Taylor1, J G Fox, N S Akopyants, D E Berg, N Thompson, B Shames, L Yan, E Fontham, F Janney, F M Hunter.   

Abstract

The gastric pathogen Helicobacter pylori establishes long-term chronic infections that can lead to gastritis, peptic ulcers, and cancer. The species is so diverse that distinctly different strains are generally recovered from each patient. To better understand the dynamics of long-term carriage, we characterized H. pylori isolates from initial and follow-up biopsy specimens from a patient population at high risk of H. pylori infection and gastric cancer. Eighty-five isolates were obtained from 23 patients and were analyzed by genomic restriction enzyme analysis, arbitrarily primed PCR fingerprinting, (random amplified polymorphic DNA analysis), and/or restriction of specific PCR-amplified genes (restriction fragment length polymorphism analysis). A single strain was found in sequential biopsy specimens from 12 of 15 patients (80%) receiving sucralfate. In the remaining three patients treated with sucralfate, two strains were identified in two patients and three strains were identified in the third patient. In contrast, a single strain was found in sequential biopsy specimens from only three of eight patients (37%) receiving bismuth, metronidazole, and nitrofurantoin. Two strains were identified in five other patients receiving bismuth-antibiotic (63%). Immunoglobulin G antibodies to H. pylori were present in the sera of all patients. Thus, H. pylori colonization can persist for long periods (up to at least 4 years), despite high titers of immunoglobulin G antibodies in serum. Resistance to metronidazole was noted in some strains before and/or after treatment, but all strains remained susceptible to amoxicillin, tetracycline, and nitrofurantoin. We conclude that H. pylori genotypes, as measured by several sensitive DNA fingerprinting methods, can remain stable for years in vivo, despite the acquisition or loss of drug resistance, circulating antibody, or exposure to antibiotics or sucralfate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790461      PMCID: PMC228068          DOI: 10.1128/jcm.33.4.918-923.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only.

Authors:  N Figura; P Guglielmetti; A Rossolini; A Barberi; G Cusi; R A Musmanno; M Russi; S Quaranta
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

2.  Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities.

Authors:  D Morgan; W Kraft; M Bender; A Pearson
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

3.  Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile.

Authors:  A E Simor; B Shames; B Drumm; P Sherman; D E Low; J L Penner
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

4.  Gastric glycerolipid as a receptor for Campylobacter pylori.

Authors:  C A Lingwood; H Law; A Pellizzari; P Sherman; B Drumm
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

5.  Comparisons between degree of histological gastritis and DNA fingerprints, cytotoxicity and adhesivity of Helicobacter pylori from different gastric sites.

Authors:  R J Owen; M Desai; N Figura; P F Bayeli; L Di Gregorio; M Russi; R A Musmanno
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

6.  Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents.

Authors:  C A McNulty; J C Dent
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

7.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.

Authors:  T L Cover; C P Dooley; M J Blaser
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

8.  The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

Authors:  C S Goodwin; P Blake; E Blincow
Journal:  J Antimicrob Chemother       Date:  1986-03       Impact factor: 5.790

9.  N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen.

Authors:  D G Evans; D J Evans; J J Moulds; D Y Graham
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

10.  Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma.

Authors:  J G Fox; P Correa; N S Taylor; D Zavala; E Fontham; F Janney; E Rodriguez; F Hunter; S Diavolitsis
Journal:  Am J Gastroenterol       Date:  1989-07       Impact factor: 10.864

View more
  68 in total

1.  Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium.

Authors:  M Matsumura; Y Hikiba; K Ogura; G Togo; I Tsukuda; K Ushikawa; Y Shiratori; M Omata
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  High-level genetic diversity in the vapD chromosomal region of Helicobacter pylori.

Authors:  P Cao; T L Cover
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

3.  iceA genotypes of Helicobacter pylori strains isolated from Brazilian children and adults.

Authors:  A A Ashour; G B Collares; E N Mendes; V R de Gusmão; D M Queiroz; P P Magalhães; A S de Carvalho; C A de Oliveira; A M Nogueira; G A Rocha; A M Rocha
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Clustering of South African Helicobacter pylori isolates from peptic ulcer disease patients is demonstrated by repetitive extragenic palindromic-PCR fingerprinting.

Authors:  M Kidd; J C Atherton; A J Lastovica; J A Louw
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

5.  DNA fingerprinting of single colonies of Helicobacter pylori from gastric cancer patients suggests infection with a single predominant strain.

Authors:  S Miehlke; R Thomas; O Guiterrez; D Y Graham; M F Go
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

Review 6.  Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes.

Authors:  H X Xia; N J Talley; C T Keane; C A O'Morain
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

7.  Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection.

Authors:  S L Hazell; H M Mitchell; G Hanna; G Daskalopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-07       Impact factor: 3.267

8.  Differences in genome content among Helicobacter pylori isolates from patients with gastritis, duodenal ulcer, or gastric cancer reveal novel disease-associated genes.

Authors:  Carolina Romo-González; Nina R Salama; Juan Burgeño-Ferreira; Veronica Ponce-Castañeda; Eduardo Lazcano-Ponce; Margarita Camorlinga-Ponce; Javier Torres
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

9.  Expanding allelic diversity of Helicobacter pylori vacA.

Authors:  L J van Doorn; C Figueiredo; R Sanna; S Pena; P Midolo; E K Ng; J C Atherton; M J Blaser; W G Quint
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates.

Authors:  G Wang; Q Jiang; D E Taylor
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.